Rationalization of costs for antibiotic therapy of community-aquiredpneumonia in hospital
Keywords:community-acquired pneumonia, antibiotic therapy, ATC/DDD-methodology, cost minimization analysis, NNT-index
Topicality. Community-acquired pneumonia (CAP) is the leading cause of death in the group of infectious diseases and leads to huge economic damage in all countries of the world. To rationalize the choice of medicines and minimize the costs for treatment of CAP without reducing its effectiveness, pharmacoeconomic studies in this area are important.
Aim. To minimize the costs of antibiotic therapy for inpatients with CAP without reducing the effectiveness of treatment based on cost minimization analysis and NNT coefficient calculation.
Materials and methods. Retrospective analysis of medical records andtreatment sheets of inpatients with community-acquired pneumonia; analysis of the Protocols for treatment of community-acquired pneumoniaaccording to the order of the Ministry of Health of Ukraine No. 128 of March 19, 2007; frequency analysis of used antibiotics; ATC/DDD-methodology; cost minimization analysis.
Results and discussion. It has been established correspondence of used antibiotics for inpatients with a list of recommended antibiotics in Protocol of treatment of CAP by order of Ministry of Health of Ukraine. It has been found that when using the cheapest generics of antibiotics for the treatment of CAP, a significant saving of money is obtained.
Conclusions. It is shown that for the money spent on antibiotic therapy of 1000 inpatients treated by the most expensive generic with INN cefepime, treatment of 3.670 patients can be provided when replacing the cheapest generic; with INN ceftriaxone – 14.740 patients; with INN levofloxacin – 3.290 patients; with INN amoxicillin and clavulanic acid – 2.470 patients; with INN azithromycin – 8.100 patients and with INN amikacin – 3.150 patients.
Honcharov, K. A. (2015). Osoblyvosti diahnostyky i likuvannia nehospitalnoi pnevmonii virusno–bakterialnoi etiolohii netiazhkoho perebihu u viiskovosluzhbovtsiv Zbroinykh syl Ukrainy.Kyiv, 5.
Shcherbeniuk, N. V. (2013). Visnyk problem biolohii i medytsyny, 3 (2), 248–251.
Bieliaieva, O. I. (2015). Optymizatsiia likarskoho zabezpechennia ditei khvorykh na pnevmoniiu. Odesa, 95.
Sukhin, R. Ye. (2006). Optymizatsiia diahnostyky ta likuvannia nehospitalnoi pnevmonii z netiazhkym perebihom u khvorykh, yaki ne potrebuiut hospitalizatsiiu. Kyiv, 13.
Bieliaieva, O. I. (2015). Optymizatsiia likarskoho zabezpechennia ditei khvorykh na pnevmoniiu. Odesa, 6.
6. Protokoly likuvannia nehospitalnoi pnevmonii za nakazom MOZ Ukrainy № 128 vid 19.03.2007. Pro zatverdzhennia klinichnykh protokoliv nadannia medychnoi dopomohy za spetsialnistiu «Pulmonolohiia». Available at: http://www.moz.gov.ua/ua/portal/dn_20070319_128.html
Derzhavnyi reiestr optovo–vidpusknykh tsin stanom na 14.01.2016. Available at: http://www.moz.gov.ua/ua/portal/
WHO Collaborating Center for Drug Statistics Methodology. Available at: http://www.whocc.no/atc_ddd_index/
Germaniuk, T. A., Ivko, T. I. (2014). Metodolohiia marketynhovykh, farmakoepidemiolohichnykh ta farmakoekonomichnykh doslidzhen u farmatsii. Vinnytsia: Nilan–LTD, 14–16.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).